Naïve CD8+ and CD4+ T cells are activated by mature dendritic cells (DCs), the professional tumor antigen presenting cells (APCs), to become effector cells through TCR binding to “stimulating complexes” on DCs (priming phase). The gene discussed is CD8A; the disease is neoplasm.